Our Services
Medical Information
Helpful Resources
Published on: 9/24/2026
Most average-risk adults over 40 do well with a professional full-body skin exam every one to two years, paired with a monthly self-check at home. Screening moves to every 6 to 12 months, or even every 3 months, for people with fair skin, many or atypical moles, significant sun or tanning bed exposure, a personal or family history of melanoma or other skin cancers, or a suppressed immune system. Any new, changing, itching, bleeding, or non-healing spot warrants a visit right away, no matter when your last exam was. Because age, risk factors, and skin type all shift the right interval, there are several important details to weigh before settling on a schedule, all explained below.
If you have noticed a mole that looks different, a patch that will not heal, or you simply are not sure whether your next exam should be in three months or two years, a few minutes of clarity can help you act at the right time rather than wait and worry. Take a free, instant, online symptom check to understand what your skin changes could mean and what step makes sense next.
Last reviewed for medical accuracy: 09/24/2026
As you enter your 40s, your skin’s ability to repair sun damage slows down. Regular, full-body skin checks become a key part of staying ahead of skin cancer, including basal cell carcinoma, melanoma and squamous cell carcinoma. Here’s a clear guide—backed by dermatology experts—on how often to schedule professional exams, what to watch for (including squamous cell carcinoma photos for reference) and practical steps to keep your skin healthy.
Most dermatology associations, including the American Academy of Dermatology (AAD), agree on this baseline:
Squamous cell carcinoma (SCC) often appears as:
Comparing your spots to squamous cell carcinoma photos online can help you spot potential warning signs before your appointment. Look for irregular borders, rapid growth or any lesion that bleeds easily.
Monthly self-exams help you notice new or changing spots:
Use a full-length mirror plus a hand mirror.
Follow the “ABCDE” guideline for moles:
Pinch and feel any rough, scaly patches—they may indicate early SCC.
Photograph suspicious lesions to share with your dermatologist.
Don’t wait for your annual exam if you notice:
For non-urgent guidance, you might consider a free, online symptom check, using the doctor approved Ubie Symptom Checker to help you decide if immediate evaluation is needed.
Skin checks aren’t meant to alarm you—they’re your best tool for early detection when treatment is simplest. Staying on schedule with professional exams and self-checks gives you confidence, not fear.
Regular full-body skin checks after age 40 are an investment in your long-term health. An annual exam is standard for most, with twice-yearly visits if you have elevated risk. Combine professional screening with monthly self-exams, sun-safe habits and prompt attention to any suspicious spots—especially those resembling images in squamous cell carcinoma photos—to stay one step ahead.
Always speak to a doctor about anything that could be life-threatening or serious. Your healthcare provider can tailor screening frequency to your personal risk and guide you through any findings.
(References)
* Brandt TP. Skin cancer screening. Med Clin North Am. 1996 Jan;80(1):99-114. doi: 10.1016/s0025-7125(05)70429-6. PMID: 8569303.
* Sturm D. [Skin cancer screening]. MMW Fortschr Med. 2010 Oct 7;152(40):38-40. doi: 10.1007/BF03367162. PMID: 21049641.
* Collins MK, Secrest AM, Ferris LK. Screening for melanoma. Melanoma Res. 2014 Oct;24(5):428-36. doi: 10.1097/CMR.0000000000000104. PMID: 24999755.
* Robinson JK, Halpern AC. Cost-effective Melanoma Screening. JAMA Dermatol. 2016 Jan;152(1):19-21. doi: 10.1001/jamadermatol.2015.2681. PMID: 26465644; PMCID: PMC4862863.
* Jørgensen KJ. Melanoma Screening. Dermatology. 2017;233(5):410-411. doi: 10.1159/000484948. Epub 2017 Dec 15. PMID: 29241216.
* Bolick NL, Geller AC. Epidemiology of Melanoma. Hematol Oncol Clin North Am. 2021 Feb;35(1):57-72. doi: 10.1016/j.hoc.2020.08.011. Epub 2020 Oct 26. PMID: 33759773.
* Eggen AC, Wind TT, Bosma I, Kramer MCA, van Laar PJ, van der Weide HL, Hospers GAP, Jalving M. Value of screening and follow-up brain MRI scans in patients with metastatic melanoma. Cancer Med. 2021 Dec;10(23):8395-8404. doi: 10.1002/cam4.4342. Epub 2021 Nov 5. PMID: 34741440; PMCID: PMC8633235.
* Elwood M, Aitken J, Soyer P. Melanoma Screening. JAMA Dermatol. 2022 Nov 1;158(11):1332-1333. doi: 10.1001/jamadermatol.2022.3907. PMID: 36129701.
* Swerlick RA. Melanoma Screening-Reply. JAMA Dermatol. 2022 Nov 1;158(11):1333. doi: 10.1001/jamadermatol.2022.3906. PMID: 36129718.
* Hübner J, Schumann L, Eisemann N, Katalinic A, Beckhaus J. Population Skin Cancer Screening and Melanoma Mortality Rates. JAMA Dermatol. 2026 Aug 1;162(8):775-779. doi: 10.1001/jamadermatol.2026.1527. PMID: 42268621; PMCID: PMC13254806.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.